Inicio | Buscar

Buscar

Resultados de la búsqueda

Anti-PD1 2C12 in adult patients with advanced non-small cell lung cancer and unresectable or metastatic melanoma. Phase I-II

... Second-degree specialist in Oncology Affiliation:  National Institute of Oncology and Radiobiology (INOR) Postal ...

Clinical Trials - CIM - 17/11/2025 - 2:49pm

Paclitaxel/Radiotherapy/Cisplatino for cervical cancer

... Medical oncology Affiliation:  ... Medical oncology Affiliation:  ...

Clinical Trials - SSA - 27/11/2025 - 3:31pm

Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy.

... Impact of Recombinant Human Erythropoietin(ior EPO-CIM)in oncology pediatric patients with post chemo and /or radiotherapy. ... Cabanas Armada,MD.Second degree specialist in Oncology. Havana City,William Soler Children´s Hospital,Caridad Verdecia ...

Clinical Trials - CIMAB - 08/11/2013 - 9:51am

Evaluation of the safety and the therapeutic effect of the Guanabana infusion in patients with breast cancer

... cancer (according to the American Society of Clinical Oncology, ASCO) classification. 2. Recently diagnosed breast cancer (within 6 ...

Clinical Trials - SSA - 27/11/2025 - 4:25pm

Anti-PD1 2C12 en pacientes adultos con cáncer de pulmón de células no pequeñas avanzado y melanoma irresecable o metastásico. Fase I-II

... Cooperativo Oncológico del Este (Eastern Cooperative Oncology Group). • Pacientes sin antecedentes de malignidad previa, con ... a brief narrative review. Clinical and Translational Oncology. 2024;26(10):2431-43. 2. Kim MS, Prasad V. Pembrolizumab for all. ...

Ensayos Clínicos - CIM - 17/11/2025 - 2:48pm

Safety and therapeutic effect of administration of Jusvinza in the chronic stage of Chikungunya infection

... First-degree specialist in Oncology Affiliation:  ...

Clinical Trials - CIGB - 17/11/2025 - 4:46pm

NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer

... First grade specialist in Oncology Affiliation:  National Institute of Oncology and Radiobiology (INOR) Postal ...

Clinical Trials - CIM - 22/12/2016 - 10:47am

Efficacy and safety of the monoclonal antibody nimotuzumab plus FOLFOX vs. FOLFOX as first-line treatment of patients with unresectable, left-sided, metastatic colorectal cancer. Phase I/II

... First degree specialist in Oncology Affiliation:  ... Santa Cruz More MD, First degree specialist in Clinical Oncology Recruitment status Section to ...

Clinical Trials - CIM - 12/08/2025 - 12:26pm

Oncoxin®-Viusid®- Calidad de vida de pacientes portadores de adenocarcinoma colorrectal metastásico-adultos-Fase II.

... 2016;18(12):1221-1228. 9. European Society for MedicaL Oncology. Tumores del estroma gastrointestinal (GIST): Guía de Práctica ... y seguimiento. Elaborada por la ESMO 2014. Annals of Oncology 25 (Supplement 3): iii21-iii26, 2014. Accesible en: ... patients with metastatic colorectal cancer. Annals of Oncology 2016;27(8):1386-1422. 24. Folprecht G, Gruenberger T, Bechstein W. ...

Ensayos Clínicos - CATALYSIS - 04/08/2025 - 1:34pm

Oncoxin-Viusid/Adenocarcinoma pancreático/Adultos/Fase II

... cancer mortality predictions for the year 2014. Annals of Oncology 2014, pp. 1-7. 5. Burris HA 3rd, Moore MJ, Andersen J, et al.: ... in Metastatic Colorectal Carcinoma: The KRAS/BRAF Pathway. Oncology 2009;77(suppl 1):57–68. 21. da Cunha Santos, G.; Dhani, N.; Tu, ...

Ensayos Clínicos - CATALYSIS - 23/07/2025 - 3:16pm